Oramed Pharm (OJU1) Stock Forecast & Price Target
OJU1 Analyst Ratings
There are no analyst ratings in the last 3 months.
OJU1 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | 10/31/26 | ||
| Google Biotechnology | TipRanks - Google | EUR 4.02 | hold | 7.81%Upside | Reiterated | 10/31/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | 10/31/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | 10/31/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 4.02 | hold | 7.81%Upside | Reiterated | 10/31/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 4.02 | buy | 7.81%Upside | Reiterated | 10/31/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/31/26 | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/31/26 | EUR 4.02 | hold | 7.81%Upside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/31/26 | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/31/26 | EUR 4.02→EUR 3.57 | hold | -4.17%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/31/26 | EUR 4.02 | hold | 7.81%Upside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/31/26 | EUR 4.02 | buy | 7.81%Upside | Reiterated | TipRanks - xAI |
Best Analysts Covering Oramed Pharm
Copying xAi Biotechnology's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -7.00% per trade.
Copying xAi Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -8.80% per trade.
Copying xAi Biotechnology's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -8.80% per trade.
OJU1 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, OJU1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OJU1 average Analyst price target in the past 3 months is ―.
OJU1 Financial Forecast
OJU1 Earnings Forecast
Next quarter’s earnings estimate for OJU1 is EUR 2.46 with a range of ― to ―. The previous quarter’s EPS was EUR 2.46. OJU1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year OJU1 has Performed in-line its overall industry.
OJU1 Sales Forecast
Next quarter’s sales forecast for OJU1 is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. OJU1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year OJU1 has Performed in-line its overall industry.